News of Note—Pfizer, Sanofi Pasteur and more
admin 31st July 2018 Uncategorised 0Here is some other vaccine news of note for the week. More: News of Note—Pfizer, Sanofi Pasteur and more Source: fierce
read more
Here is some other vaccine news of note for the week. More: News of Note—Pfizer, Sanofi Pasteur and more Source: fierce
read morePfizer’s new three-unit structure may be all about driving growth for now. But don’t count out a long-awaited generics divestment down the line. That’s the message executives had for investors Tuesday as they clarified the reasoning behind Pfizer’s latest reorganization.
read moreWith an ambition to expand its position as a leading dermatology company, Leo Pharma has agreed to acquire Bayer’s prescription dermatology business, which delivered €280 million ($328 million) in 2017 sales. More: Bayer to sell prescription dermatology unit and transfer
read moreAs much as Sanofi has struggled with diabetes and generic drugs the past few years, it could typically count on vaccines and Genzyme to come to the rescue. This quarter, Genzyme played its usual lifeguard role, but vaccines fell down
read moreRBC Capital Markets asked investors to name their top pick as a replacement for outgoing Gilead CEO John Milligan. The winner, by a wide margin, has the deep oncology experience Gilead will need as its once-blockbuster hepatitis C franchise continues
read moreCopycat of blockbuster breast cancer drug is Pfizer’s first oncology biosimilar More: EC approves Pfizer's Herceptin biosimilar Source: News
read more© 1994 - 2025 B.M. Pharmaceuticals